CTLA4 and cholangiocarcinoma: Another outcome of the study of Cao et al. was that the immune checkpoints, including IDO1, PD-L1, FASLG, CD80, HAVCR2, CD73, CTLA-4, LGALS9, VTCN1, and TNFRSF14, are associated with poor prognosis in CCA patients.